Johnson & Johnson's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Investments" stands at -20.42 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025.
Johnson & Johnson's third quarter result of -0.542 Billion USD for the item "Investments" represents an increase of 97.03 percent compared to it's second quarter result.
Also, Johnson & Johnson's third quarter result of -0.542 Billion USD for the item "Investments" represents an increase of 82.67 percent compared to it's third quarter result of last year.
Looking again at the trailing twelve months series (TTM), Johnson & Johnson's third quarter result of -20.42 Billion USD for the item "Investments" represents an increase of 11.24 percent compared to it's second quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an decrease of -1.94 Billion United States Dollars compared to the value the year prior.
The 1 year change is -1.94 Billion United States Dollars.
The 3 year change is -17.62 Billion United States Dollars.
The 5 year change is -10.46 Billion United States Dollars.
The 10 year change is -15.24 Billion United States Dollars.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Investments | 905,699,262,464.00 |
![]() | AbbVie Inc - Investments | 399,570,305,024.00 |
![]() | Roche Holding AG - Investments | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Investments | 280,205,508,085.11 |
![]() | Novartis AG - Investments | 255,096,620,580.91 |